Health Condition 1: L80- Vitiligo Health Condition 2: L409- Psoriasis, unspecified
Conditions
Interventions
Intervention1: NIL: NIL
Sponsors
Sri Ramachandra Institute of Higher Education and Research DU
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male or nonpregnant female patients aged above 18 year 2. Patients with dermatological conditions like vitiligo and psoriasis 3. Active vitiligo, defined as appearance of new areas of depigmentation or progression of existing areas of depigmentation 4. Active psoriasis with shades of purple or gray scale on brown or Black skin and pink or red with silver scale on white skin.
Exclusion criteria
Exclusion criteria: 1. Pregnancy or breastfeeding women 2. Alcohol or drug abuse 3. Uncooperative patients 4. Skin malignancies (current or a history of skin malignancy within 5 years preceding screening)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The prevalence of psoriasis and vitiligo, patient satisfaction with their current treatment regimenTimepoint: This study involves assessing the prevalence of psoriasis and vitiligo and patient satisfaction with the treatment with their current treatment regimen using questionnaire so this study do not have any time points. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. The genetic risk factors involved & to understand the incidence of comorbidities due to the disease. 2. The impact of COVID-19 vaccination on the disease. Timepoint: The genetic risk factors, co morbidities & impact of COVID 19 vaccine will be obtained using questionnaire for this study so there is no time points for this study | — |
Countries
India
Contacts
Public ContactHemapriya V
Sri Ramachandra Institute of Higher Education and Research
Outcome results
None listed